The Charing Cross Symposium (CX), first took place in 1978 at Charing Cross Hospital, Hammersmith, London and has by now become the longest running vascular and endovascular symposium in Europe and one of the largest in the world.
London (UK) has been the host city of CX ever since. Until 1998, the symposium was held at Charing Cross Hospital, and between 1999 and 2012 at Imperial College. In 2013, it moved to National Hall, Olympia, and in 2014 to Olympia Grand.
The first CX had 100 attendees. In 2017, the Charing Cross Symposium – Consensus Update had 4,125 participants, from 84 countries, making it a leading global event.
The Charing Cross Symposium raises vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle. Controversies will be discussed in 2018.
CX programme and format
All Charing Cross Symposia are distinguished by a unique and logical programme, which focuses on identifying evidence for optimal vascular disease management from head to toe, catering for all vascular specialists.
Debate and emphasis on interaction with an expert audience are key aspects of the CX’s style. Education, Innovation and Evidence are CX core values.
Short presentations and time keeping are key characteristics of the CX sessions; these enable the right time for comments and questions by the audience.
At the sessions, there is a chairman who monitors time, encourages audience and speaker interaction and conducts the discussion; there is also a moderator who assists the chair with questions to and from the audience.
Who should attend CX?
- Vascular and endovascular surgeons
- Cardiovascular specialists
- Imaging diagnosticians
- Neurovascular interventional radiologists
- Stroke neurologists
- Vascular scientists and nurses
- Physicians in training